Abbott - Model MitraClip™ G5 -Transcatheter Edge-to-Edge Repair (TEER) System for Mitral Valve
The MitraClip™ G5 Transcatheter Edge-to-Edge Repair (TEER) system by Abbott is a sophisticated solution for treating mitral valve regurgitation (MR). It is particularly indicated for patients with symptomatic primary or secondary MR, classified as significant. The G5 system is an evolution of Abbott's TEER technology, designed to enhance procedural control and efficiency. Features include easy handling, precise positioning, and intuitive deployment, owing to its advanced attachment mechanisms and securement features that simplify connection and disconnection procedures. The system offers different clip sizes—NTW, XTW, NT, and XT—allowing for tailored repairs based on an individual patient's mitral valve anatomy. The wider grasping area of the NTW and XTW clips aims to further reduce regurgitant volume effectively. The system incorporates controlled gripper actuation, offering simultaneous or independent leaflet grasp, which helps confirm and optimize leaflet stabilization. Proven in clinical studies, the MitraClip system delivers consistent MR reduction and improved patient quality of life.
G5 is the next evolution of the MitraClip TEER system offering easy handling, precise positioning, and intuitive deployment that enhances both control and efficiency, allowing you to focus on what matters most your patients.
PATIENTS WHO BENEFIT
A better quality of life is possible for your patients with Mitral Regurgitation (MR)
The MitraClip G5 System is indicated for patients with symptomatic primary (degenerative) or secondary (functional) significant mitral regurgitation (MR ≥ 2+).
The catalyst for a significant evolution in MR guidelines MitraClip is the first TEER (TMVr) therapy recommended by AHA/ACC/HFSA and ESC/EACTS guidelines and APSC recommendations for select primary and secondary MR patients.